Po Yee Mak - JoVE Visualize

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Blood|March 7, 2014

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistanceRodrigo Jacamo, Ye Chen, Zhiqiang Wang, et al.

Blood Advances|August 23, 2021

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosisNaveen Pemmaraju, Bing Z Carter, Prithviraj Bose, et al.

Blood|June 20, 2023

Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cellsBing Z Carter, Po Yee Mak, Muharrem Muftuoglu, et al.

The Journal of Clinical Investigation|June 16, 2026

Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1Matthew Tcheng, Veronique Voisin, Geethu Emily Thomas, et al.

Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Blood|March 7, 2014

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistanceRodrigo Jacamo, Ye Chen, Zhiqiang Wang, et al.

Blood Advances|August 23, 2021

Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosisNaveen Pemmaraju, Bing Z Carter, Prithviraj Bose, et al.

Blood|June 20, 2023

Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cellsBing Z Carter, Po Yee Mak, Muharrem Muftuoglu, et al.

The Journal of Clinical Investigation|June 16, 2026

Elevated mitochondrial protein import in acute myeloid leukemia increases reliance on mitochondrial protease LONP1Matthew Tcheng, Veronique Voisin, Geethu Emily Thomas, et al.

Pageof 3